Previous Article | Next Article ![]()
Eukaryotic Cell, February 2007, p. 222-234, Vol. 6, No. 2
1535-9778/07/$08.00+0 doi:10.1128/EC.00182-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Department of Microbiology and Immunology, Tulane University Health Sciences Center,1 Departments of Pediatrics,2 Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center,3 Research Institute for Children, New Orleans, Louisiana,4 Departments of Molecular Genetics and Microbiology,5 Medicine, Duke University Medical Center, Durham, North Carolina6
Received 14 June 2006/ Accepted 17 November 2006
|
|
|---|
|
|
|---|
Protein O mannosylation is initiated in the endoplasmic reticulum by protein O-mannosyltransferases (Pmts) that catalyze the transfer of mannose from the sugar donor, dolichol phosphate-mannose, to the hydroxyl groups of serine and threonine residues in the secreted acceptor protein. The Pmt enzymes have been extensively studied in S. cerevisiae, for which seven Pmt proteins have been described previously (37). Recently, five Pmts were described for C. albicans and three for the fission yeast Schizosaccharomyces pombe (32, 46). Two PMT genes in S. pombe, OMA1 and OMA4, are not essential for viability. However, oma1
and oma4
mutants exhibit abnormal cell morphology, altered cell wall structure, and partial cell separation defects (46). The third S. pombe PMT gene, OMA2, is an essential gene (46). In addition, each of the two protein O-mannosyltransferases, Pomt1 and Pomt2, are crucial for growth and development in higher eukaryotes such as Drosophila melanogaster and Homo sapiens (1, 12, 14, 41).
The family of Pmts is comprised of three subfamilies, represented in S. cerevisiae by the Pmt1, Pmt2, and Pmt4 proteins, which are grouped according to phylogenetic analysis and conservation within three main sequence motifs (9). In S. cerevisiae, Pmt1 and Pmt2 subfamily members function together as heterodimers, while those of the Pmt4 subfamily form homodimers (5, 8). Likewise, in S. pombe, Pmt1 and Pmt2 subfamily members also function as heterodimers (46). Furthermore, these protein O-mannosyltransferase dimers demonstrate specificity toward protein substrates based on Pmt subfamily (6).
The opportunistic pathogen Cryptococcus neoformans is a ubiquitous, encapsulated yeast that is acquired by a human host through inhalation. In most cases, infection is asymptomatic. However, in individuals with a predisposing immune system deficiency, this organism can disseminate throughout the body with a predilection for the central nervous system, where it can cause a life-threatening meningoencephalitis. In contrast to other human fungal pathogens, C. neoformans is a basidiomycete. In addition, C. neoformans is not a human commensal microorganism but is found primarily in decaying vegetation. Therefore, this yeast must be able to survive equally well in the environment and in the human host. C. neoformans displays unique virulence determinants, such as the formation of a large polysaccharide capsule and the production of melanin (16-18).
In this study, we sought to examine the significance of protein O mannosylation in C. neoformans. Mannosylated proteins are predominant immunogens of this opportunistic fungal pathogen (19). Also, defective protein O mannosylation is known to result in morphological defects in other fungi, and subtle morphological changes have been associated with considerable alterations in fungal survival in vivo (3, 34). Here we have identified three Pmt homologues in C. neoformans and examined the role of one such Pmt homologue, designated Pmt4, in cell integrity, cell separation, and pathogenesis.
|
|
|---|
strains used in this study were derived from the serotype A strain, H99. F99 is a Ura derivative of H99 (44). Strains described in this study are the pmt4 mutant GMO1 (pmt4::URA5) and the pmt4 plus PMT4 reconstituted strain GMO3 (pmt4::URA5 PMT4). The S. cerevisiae strain CFY3 (MATa ade2-1 his3-
200 leu2-3,112 trp1-
901 ura3-52 suc2-
9 pmt1::HIS3 pmt4::TRP1) was generously provided by Sabine Strahl at the University of Heidelberg (8). Oligonucleotide primers and sequencing. Oligonucleotide primers for PCR and sequencing were synthesized by Integrated DNA Technologies, Inc. Sequencing was performed by the Tulane Gene Therapy sequencing facility, the Duke University DNA analysis facility, and Davis Sequencing. Primer sequences used in this study are as follows: GO28, 5'-GTTATTCCACCTATCATCCCAACTCC-3'; GO36, 5'-GCATG TGGTTCTTCATCTTCTACCG-3'; GO34, 5'-AGAGAATATTGAGCGAAGTTGCTCGACC-3'; GO35, 5'-AGAGAATATTCTTGCCTCCAGGAGGTGG-3'; GO44, 5'-GAGGATCCGCAGAAGCATGAGCAGCCTGCGTGGC-3'; GO45, 5'-GCGGATCCGTGCTGAATGCAGCATCAGTTCGCCG-3'; GO49, 5'-GAGAGATATCGCTGCGAGGATGTGAGCTGGAGAGC-3'; GO50, 5'-GAGAGATATCAAGCTTATAGAAGAGATGTAGAAACTAGC-3'; GO58, 5'-TCCCTACGTCGGGATGAGAAGC-3'; GO59, 5'-CCATAGAATGGCCCCTTTTGATG-3'; GO53, 5'-GAGATGGCTGTGCCCAAAAAACGTAACC-3'; GO54, 5'-CTTGGAGAAATTTAATTCTATGTCAAACC-3'; GO74, 5'-TTCTCACATCACATCCGAACATAAACAACCAGAGATGGCTGTGCCCAAAAAACG-3'; GO75, 5'-CTTTTTATTGTCAGTACTGATTAGGGGCAGGTTACTTGGAGAAATTTAATTCTATGTC-3'; GO55, 5'-GATATGGCTCTCGCTCCTCGCAAGAGG-3'; GO56, 5'-CTCATCCATCGAATGCGTCTTCTTGG-3'; GO72, 5'-TTCTCACATCACATCCGAACATAAACAACCAGATATGGCTCTCGCTCCTCG-3'; GO73, 5'-CTTTTTATTGTCAGTACTGATTAGGGGCAGGTTACTCATCCATCGAATGCGTCTTC-3'; FOX47, 5'-GTTATGTCATATCCCAATCC-3'; FOX50, 5'-AATCTGCAGGTCGGGGTAGG-3'; PW371, 5'-CAGTCTAAGCGAGGTATTCTTACCTTGAAGTA-3'; PW372, 5'-GGTGATGACCTGACCGTCAGGAAGCTCGTAAG-3'.
C. neoformans strain construction. PMT homologs were identified by tblastn searches using S. cerevisiae Pmt1, 2, and 4 protein sequences against The Institue for Genomic Research (www.tigr.org) and H99 genomic databases (H99 sequencing project, Duke IGSP Center for Applied Genomics and Technology; http://cneo.genetics.duke.edu) (21). PMT4 was PCR amplified from the H99 genomic template using primers GO28 and GO36 and cloned into pCR4-TOPO (Invitrogen) to generate pGMO11. The URA5 marker was also PCR amplified using H99 genomic DNA as a template and primers GO34 and GO35, introducing SspI sites at both ends of the fragment. The amplicon was subsequently cloned into pCR4-TOPO to generate pGMO13. For construction of the disruption allele, URA5 was released from pGMO13 by SspI digestion and blunt-end ligated into the EcoRV site of pGMO11. The PMT4::URA5 construct was then PCR amplified to generate a linear disruption allele and gel purified for use in biolistic transformation into F99 as previously described (40).
For reconstitution of the pmt4::URA5 strain, the PMT4 gene, including approximately 1.4 kb of the 5' untranslated region and the 880-bp 3' untranslated region was PCR amplified with primers GO44 and GO45 and cloned in pCR4-TOPO to generate pGMO16. The NAT marker for nourseothricin resistance was PCR amplified using pGMC200 template with primers GO49 and GO50 and cloned into pCR4-TOPO. The NAT marker was released by EcoRV digestion and blunt-end ligated into PmeI-digested pGMO16 to generate pGMO18, which was used to transform the pmt4 mutant strain (GMO1) by biolistic transformation to generate strain GMO3. Transformants were screened by PCR to demonstrate the presence of an intact PMT4 gene and confirmed by Southern blot analysis.
Southern analysis. Genomic DNA was isolated as described previously (31). Approximately 10 µg genomic DNA was digested with SacI and HindIII, resolved on a 1% agarose gel, and transferred to a Nytran membrane (Schleicher and Schuell Bioscience). The probe specific for PMT4 exon 3 was PCR amplified with primers GO58 and GO59 and labeled with digoxigenin (DIG) using the DIG-easy labeling kit (Roche). Hybridization was performed according to the manufacturer's instructions (Roche), and signals were visualized by autofluorography.
Northern blot analysis. C. neoformans strain H99 was incubated to mid-log phase in yeast-peptone-dextrose (YPD) medium, pelleted, washed, and incubated under the following conditions for 1 h: YPD at 30°C, YPD at 37°C, synthetic complete minus glucose (SC-glucose) at 30°C, and synthetic low-ammonium dextrose at 30°C. C. neoformans strains H99 and GMO1 were incubated to mid-log phase in YPD medium, pelleted, washed, and incubated under the following conditions for 1 h: YPD 30°C, YPD 39°C, YPD 39°C plus 0.5 µg/ml amphotericin B, or YPD 30°C plus 100 µg/ml hygromycin B for 60 min. Total RNA was extracted using Trizol reagent (Invitrogen), and further sample purification was performed using the RNeasy cleanup kit (QIAGEN). Twelve micrograms of total RNA was resolved on a 1.2% agarose gel, transferred to a Nytran membrane, and probed with a 32P-random-labeled probe (All-in-one random prime labeling mix; Sigma) in UltraHyb hybridization buffer (Ambion). The PMT4 probe template was amplified with primers GO58 and GO59. The FKS1 probe template was amplified with primers FOX47 and FOX50, and the ACTIN probe template was amplified with primers PW371 and PW372.
Fluorescence microscopy. C. neoformans strains were grown in liquid YPD at 30°C for 24 h, pelleted, fixed, and stained with Alexa fluor 488-conjugated wheat germ agglutinin (WGA; Molecular Probes) as previously described (4). Cells were viewed under fluorescent and phase contrast microscopy using an Olympus BX51 microscope and images captured with MagnaFIRE software version 1.0 (magnification, x5).
TEM. Transmission electron microscopy (TEM) was performed by the Molecular Microbiology Imaging Facility at Washington University in St. Louis. C. neoformans strains were grown in liquid YPD at 30°C to mid-log phase and processed by either KMnO4 fixation, acetone dehydration, and lead citrate staining or fixed with paraformaldehyde and glutaraldehyde, followed by postfixation in osmium tetroxide and dehydration in ethanol.
Growth characterization of C. neoformans strains. C. neoformans strains were grown in liquid YPD at 30°C to mid-log phase, counted, and normalized to 2 x 107 CFU/ml. Serial dilutions were spotted onto YPD plus 0.025% sodium dodecyl sulfate (SDS) or prewarmed YPD plates at 30°C, 37°C, or 39°C and incubated for 2 days.
Antifungal susceptibility E-test. C. neoformans strains H99, GMO1, and GMO3 were grown overnight in YPD at 30°C, pelleted, and washed in sterile nanopure water. Fifty-microliter aliquots containing 5 x 105 CFU were plated on 0.5x YPD plates (25 ml medium in each plate) and allowed to dry before application of amphotericin B E-test strips (AB Biodisk, Solna, Sweden). Plates were incubated for 3 days at either 30°C or 39°C, and the MICs were determined.
Complementation of S. cerevisiae pmt1pmt4
temperature sensitivity.
ScPMT4 was PCR amplified from the wild-type genomic template with primers GO53 and GO54 and cloned into pYES2.1 (Invitrogen) to yield pYES2.1-ScPMT4. ScPMT4 was PCR amplified for gap repair with primers GO74 and GO75. CnPMT4 was PCR amplified from reverse-transcribed mRNA (SuperScriptII reverse transcription kit) using primers GO55 and GO56 and cloned into pYES2.1. CnPMT4 was PCR amplified for gap repair with primers GO72 and GO73. Gap repair was performed as described previously (28) in the S. cerevisiae pmt1pmt4
strain CFY3 with KpnI- and SphI-digested pAG36 (generous gift from the McCusker laboratory at Duke University) (10). Transformants were screened for the presence of recombined insert by PCR analysis. To test for complementation of temperature sensitivity, strains were grown to log phase in synthetic complete medium lacking uracil (SC-ura) at 25°C, adjusted to 2 x 107 CFU/ml, and serially diluted, and 5 µl of each dilution was spotted onto YPD and SC-ura plates and incubated for 4 days at 25°C and 35°C, respectively.
Isolation of cell wall proteins. Surface-associated cell wall proteins were isolated as previously described (30). Briefly, C. neoformans yeast cells were grown in liquid YPD at 37°C to stationary phase and cells were collected by centrifugation. Cells were frozen at 80°C and then resuspended in ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, Complete protease inhibitor [Roche]). Cells were mechanically lysed with an equal volume of 0.5-mm glass beads in a mini-bead beater (Biospec Products). Cell wall fractions were isolated and washed as described previously (21). Cell surface-associated proteins were then released in SDS extraction buffer (50 mM Tris-HCl, pH 8.0, 0.1 M EDTA, 2% SDS, 10 mM dithiothreitol [DTT]) by boiling at 100°C for 10 min and isolated by pelleting at 13,000 rpm for 10 min (accuSpin Micro R; Fisher Scientific). SDS-extracted proteins in the resulting supernatants were frozen at 80°C, lyophilized, and quantified using the BCA protein assay (Pierce).
One-dimensional polyacrylamide gel electrophoresis (PAGE). Samples containing 50 µg protein were precipitated in 10% trichloroacetic acid in acetone at 20°C to reduce the amount of contaminating polysaccharides, suspended in loading buffer, and run in duplicate on a 10% NuPAGE Bis-Tris gel (Invitrogen). Protein bands were silver stained using the Bio-Rad Silver Stain Plus kit. Glycosylation of proteins was detected by staining with the Pro-Q Emerald 300 glycoprotein gel and blot stain kit (Molecular Probes) and imaging with a Bio-Rad Geldoc imaging system.
Two-dimensional PAGE. Samples containing approximately 150 µg protein were precipitated in 10% trichloroacetic acid in acetone at 20°C to reduce the amount of contaminating polysaccharides. Samples were suspended in rehydration sample buffer {8 M urea, 2% 3-[(3-cholamidylpropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 50 mM DTT, 0.2% Bio-Lyte 3/10 ampholyte, 0.001% bromphenol blue (Bio-Rad)} and used to passively rehydrate Readystrip immobilized pH gradient (IPG) 11-cm, pH 5 to 8 isoelectric focusing (IEF) strips (Bio-Rad). IEF strips were focused in a PROTEAN IEF cell (Bio-Rad) at 20°C using the following program: 250 V for 15 min, 8,000 V for 2.5 h, 8,000 to 35,000 V, 500 V (hold). After isoelectric focusing, IEF strips were reduced (2% DTT) and alkylated (2.5% iodoacetamide) in SDS-PAGE equilibration buffer (6 M urea, 0.375 M Tris-HCl, pH 8.8, 2% SDS, 20% glycerol). The SDS-PAGE run was performed using Criterion XT 10% Bis-Tris precast gels (Bio-Rad) in a Bio-Rad CRITERION cell. Two-dimensional (2-D) gels were silver stained using the Bio-Rad Silver Stain Plus kit or the Blum silver stain method (2). For detection of glycoproteins, 2-D gels were blotted onto a polyvinylidene difluoride membrane and stained with the Pro-Q Emerald 300 glycoprotein gel and blot stain kit (Molecular Probes) and imaged with a Bio-Rad Versadoc imaging system.
Intravenous murine model. Female CBA/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and used between 7 and 10 weeks of age. Mice were infected intravenously in the lateral tail vein with 5 x 105 cells of C. neoformans strain H99 or GMO1. Moribund animals were sacrificed, and the day of death recorded as the following day. All mice were maintained at the Tulane University Health Sciences Center Vivarium in accordance with the American Association of Accreditation of Laboratory Animal Care guidelines.
Inhalational murine model. Female A/Jcr mice were anesthetized and infected with 1 x 105 CFU C. neoformans strain H99, GMO1, or GMO3 intranasally as previously described (43). Animal survival was determined after inoculation, using predetermined clinical endpoints as surrogate markers for mortality (inability to access food or water, severe neurological symptoms). Mice were maintained at the Research Institute for Children Animal Facility in accordance with the American Association of Accreditation of Laboratory Animal Care guidelines.
Histology. Infected brains, lungs, and spleens from sacrificed animals were formalin fixed, paraffin embedded, and sectioned on a microtome and stained with either hematoxylin and eosin or mucicarmine. Tissue processing was performed by the Tulane University School of Medicine Histology Research Services.
Motif analysis, accession numbers, and databases. ClustalW alignment was performed using MacVector, version 7.2. Accession numbers for each of the protein sequences available at GenBank and the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov) are as follows: AnPmtA(2), AACD01000088.1; AnPmt4, XM_653971 [GenBank] .1; AnPmt1, AACD01000080.1; ScPmt1, NC_001136 [GenBank] .7; ScPmt2, NC_001133 [GenBank] .6; ScPmt4, NC_001142 [GenBank] .6; CaPmt1, AF000232 [GenBank] .1; CaPmt2, AACQ01000028.1; CaPmt4, AACQ01000107.1; SpOma1, CAB16577 [GenBank] ; SpOma2, CAC36926 [GenBank] ; SpOma4, CAA16916 [GenBank] . Deduced amino acid sequences of C. neoformans Pmt proteins 1, 2 and 4 were obtained from http://fungal.genome.duke.edu for C. neoformans var. grubii serotype A strain H99. The C. neoformans PMT4 sequence was submitted to GenBank (see below).
Statistics. Prism software version 4.0a (Graphpad Software, Inc.) was used to perform a log rank test of statistical significance for the survival experiments.
Nucleotide sequence accession number. The C. neoformans PMT4 sequence was submitted to GenBank with the accession number DQ666285.
|
|
|---|
![]() View larger version (100K): [in a new window] |
FIG. 1. Conservation of Pmt sequence motifs in C. neoformans Pmt proteins. Pmt protein sequences are demonstrated from A. nidulans (An), C. neoformans (Cn), S. cerevisiae (Sc), and S. pombe (Sp). Predicted loop 5 of CnPmt4p from position Thr-342 to Asn-511 is aligned to other described or putative fungal Pmt proteins. Conserved residues within motifs A to C (described by Girrbach et al. [9]) are indicated by uppercase (>90%) or lowercase (>50%) symbols.
|
In addition to motif analysis, we also performed phylogenetic comparison between the predicted C. neoformans Pmt protein sequences and those of other fungi and higher eukaryotes. This analysis confirmed the predictions of the subfamily sequence comparisons. For example, Pmt4 was most closely related to the other fungal Pmt4 proteins, Pmt1 was most closely related to A. nidulans Pmt1, and Pmt2 was most closely related to A. nidulans Pmt(2)A (G. Olson, unpublished data).
PMT family gene expression. Northern blot analysis indicated that PMT4 is expressed during growth in liquid YPD at both 30°C and 37°C, as well as during both glucose and nitrogen starvation conditions (Fig. 2A). Although additional Northern analysis revealed that PMT1 and PMT2 are also expressed under these conditions (data not shown), PMT2 was predicted to be essential based on studies of other microorganisms, and we also predicted that Pmt1 and Pmt2 likely function together as a heterodimer. In other fungi, Pmt4 enzymatic activity is important for cell wall formation, cell integrity, and pathogenesis but is not essential for viability (34, 46). Therefore, for initial gene disruption experiments, we chose to study the PMT4 gene to assess the role of Pmt-mediated O mannosylation in C. neoformans growth and pathogenesis.
![]() View larger version (50K): [in a new window] |
FIG. 2. PMT4 gene expression, disruption, and reconstitution in C. neoformans. (A) Northern blot analysis. Wild-type strain H99 was grown to mid-log phase in liquid YPD and shifted for 60 min to the indicated growth conditions. Twelve micrograms of total RNA from each sample was resolved and probed with a 32P-labeled probe specific for exon 3 of PMT4. (B) Southern blot analysis. Ten micrograms of genomic DNA from wild-type (H99), pmt4::URA5 (GMO1), and pmt4 plus PMT4 (GMO3) strains digested with SacI and HindIII, resolved, and probed with a DIG-labeled probe specific for exon 3 of PMT4. (C) Northern blot analysis of FKS1 and PMT4 gene expression in wild-type and pmt4 mutant strains grown as described above and then shifted to the indicated conditions for 60 min. Actin is shown as a loading control.
|
PMT4 is necessary for normal cellular morphology. Microscopic observation showed that the pmt4 mutant strain grows as small aggregates of yeast cells. In contrast to wild-type cells in which budding was immediately followed by cell separation, the mother and daughter cells of the pmt4 mutant strain failed to dissociate normally. Neither extensive vortexing nor sonication disrupted the cell aggregates. Alexa Fluor 488-conjugated WGA staining of fixed and permeabilized pmt4 cells demonstrated the presence of chitin between connected cells, suggesting a partial septation defect (Fig. 3). However, the observation that the pmt4 mutant cells grew well in liquid medium and eventually separated argues against an absolute defect in septation and cell separation. Reintroduction of the wild-type PMT4 gene restored the normal budding and cell separation to the pmt4 mutant (Fig. 3).
![]() View larger version (38K): [in a new window] |
FIG. 3. PMT4 disruption results in abnormal budding morphology and defective cell separation. (A) Phase-contrast and fluorescent microscopic observation of septum formation and morphology in Alexa Fluor 488-conjugated WGA-stained C. neoformans yeast cells. (B) India ink-stained C. neoformans yeast cells after 4 days of capsule induction in Dulbecco modified Eagle medium. Magnification, x1,000.
|
![]() View larger version (93K): [in a new window] |
FIG. 4. Transmission electron microscopy of C. neoformans strains H99 (wild-type) and GMO1 (pmt4) that were grown to mid-log phase in liquid YPD at 30°C and prepared by KMnO4 fixation, acetone dehydration, and lead citrate staining (a, b, d, e, and g) or fixed with paraformaldehyde and glutaraldehyde fixation, osmium tetroxide postfixation, and dehydration in ethanol (c and f). Scale bars, 1 µm (a and b) and 200 nm (c, e, f, and g). Magnification, x4,337 (a), x6,506 (d), x21,686 (b, c, e, and f), and x17,349 (g). Arrows indicate nondegraded cell wall material. *, capsule fibers extending from the cell wall.
|
![]() View larger version (95K): [in a new window] |
FIG. 5. Effect of PMT4 disruption on sensitivity to elevated temperature, SDS, and amphotericin B. (A) C. neoformans strains H99 (wild type), GMO1 (pmt4), and GMO3 (pmt4 plus PMT4) were grown to mid-log phase, normalized to 2 x 107 CFU/ml, serially diluted, and spotted onto YPD medium (or YPD plus 0.025% SDS) and incubated for 2 days at 30°C, 37°C, or 39°C. (B) C. neoformans strains H99 (wild type), GMO1 (pmt4), and GMO3 (pmt4 plus PMT4) (5 x 105 CFU) were plated on 0.5x YPD plates and overlaid with amphotericin (AP) E-test strips for 3 days at 39°C. AP MICs (in µg/ml): H99, 0.25; GMO1, 0.125; GMO3, 0.25.
|
We also tested the effect of the pmt4 mutation on virulence-associated phenotypes. Melanin production by the pmt4 strain was identical to that of the wild type after 3 days of incubation on either L-3,4-dihydroxyphenylalanine (L-DOPA) and Niger seed medium (data not shown). Interestingly, India ink staining of the pmt4 strain incubated for four days in Dulbecco modified Eagle medium revealed a large polysaccharide capsule surrounding the clustered mutant cells, whereas wild-type cells typically grow as individual or singly budded yeast cells in this capsule-inducing medium (Fig. 3).
CnPmt4 complements an S. cerevisiae protein O-mannosyltransferase mutant.
There is currently no in vitro assay available for detecting Pmt4 enzyme activity. Therefore, CnPmt4 activity was confirmed by testing whether it could function as a protein O-mannosyltransferase to complement the temperature sensitivity of the S. cerevisiae pmt1pmt4
strain CFY3. To this end, CnPMT4 and ScPMT4 were each expressed in strain CFY3 under the control of the constitutive TEF promoter from Ashbya gossypii. Expression of either CnPMT4 or ScPMT4 restored growth at 35°C to the temperature-sensitive mutant strain (Fig. 6). In contrast, the strain transformed with empty vector was unable to grow at this elevated temperature, suggesting that CnPmt4 functions as a protein O-mannosyltransferase (Fig. 6). These results also suggest that CnPmt4 is orthologous to ScPmt4, and Pmt4-mediated O-mannosyltransferase activity is functionally conserved among these distantly related basidiomycete and ascomycete fungal species.
![]() View larger version (41K): [in a new window] |
FIG. 6. C. neoformans Pmt4 expression complements the temperature sensitivity of the S. cerevisiae pmt1pmt4 mutant. S. cerevisiae pmt1pmt4 strain CFY3 was transformed with linearized pAG36 plus ScPMT4, uncut pAG36 (vector control), or linearized pAG36 plus CnPMT4 as described in Materials and Methods. Transformants were incubated in SC-ura to exponential phase, normalized to 2 x 107 CFU/ml, serially diluted, spotted onto YPD and selective SC-ura, and incubated for 4 days at 25°C and 35°C.
|
![]() View larger version (56K): [in a new window] |
FIG. 7. The SDS-extracted cell wall protein fraction from the pmt4 mutant exhibits an altered banding pattern and decreased overall carbohydrate content. Fifty-microgram cell wall protein fractions from C. neoformans strains GMO3 (pmt4 plus PMT4) and GMO1 (pmt4) were trichloroacetic acid precipitated, suspended, and loaded in duplicate onto a 10% NuPAGE Bis-Tris gel. (left) Silver stain; (right) glycoprotein stain. Molecular masses are shown in kilodaltons. Arrows indicate prominent differences in banding patterns.
|
![]() View larger version (96K): [in a new window] |
FIG. 8. Two-dimensional gel electrophoresis analysis of SDS-extracted cell wall fractions. Protein samples (150 µg) were trichloroacetic acid precipitated and focused on pH 5 to 8 IEF strips and run in the second dimension on 10% Criterion gels. (A) Silver-stained 2-D gels from strains GMO3 (pmt4 plus PMT4) and GMO1 (pmt4). (B) Inset area of the GMO3 (pmt4 plus PMT4) silver-stained 2-D gel and corresponding blot stained for glycosylated proteins. (C) Inset area of the GMO1 (pmt4) silver-stained 2-D gel and corresponding blot stained for glycosylated proteins. Molecular masses are shown in kilodaltons.
|
In the first experiment, the WT and pmt4 mutant strains were intravenously injected into CBA/J mice, resulting in a hematogenously disseminated infection. Animal survival was assessed over 15 days. The virulence of the pmt4 mutant was significantly attenuated relative to the wild-type strain (P < 0.0002) (Fig. 9A). Given the aberrant morphology of the pmt4 mutant in vitro, histological analysis of brain, lung, and spleen tissue sections from infected mice was performed. Spleen tissue sections revealed a striking difference between animals infected with the wild-type and pmt4 mutant strains. The spleens of mice infected with wild-type C. neoformans contained numerous encapsulated organisms. In contrast, the few organisms observed in the spleens of the mice infected by the pmt4 mutant strain exhibited a branched chain pattern indicative of a separation defect, similar to the growth phenotype observed in vitro (Fig. 9B). Interestingly, the pmt4 mutant yeast cells observed in the brain and lung tissues were morphologically indistinguishable from wild-type cells (Fig. 9B).
![]() View larger version (79K): [in a new window] |
FIG. 9. Pmt4 is required for full C. neoformans virulence. (A) CBA/J mice were injected intravenously with 5 x 105 cells C. neoformans strains H99 (wild type) (n = 6) or GMO1 (pmt4 mutant) (n = 7), and the infected animals were monitored for survival. (B) Mucicarmine-stained spleen, lung, and brain tissue from intravenously infected mice. Arrow indicates C. neoformans pmt4 mutant cells in the spleen. Magnification, x100 (left) and x1,000 (right). (C) Ten A/Jcr mice were inoculated intranasally with 1 x 105 CFU C. neoformans strains H99, GMO1 (pmt4), and GMO3 (pmt4 plus PMT4) and monitored for survival.
|
|
|
|---|
Growth of the pmt4 mutant was inhibited at elevated temperature (39°C) and markedly reduced in the presence of 0.025% SDS. Furthermore, the pmt4 mutant was twice as sensitive to amphotericin B as the wild-type and reconstituted strain controls. Recently, it was demonstrated that the growth of mutants in several components of the PKC1 signaling cell integrity pathway is also inhibited at 39°C and in the presence of SDS (7). Additionally, growth of a C. albicans mnt1mnt2
strain defective in protein O-mannosyl glycan elongation was severely inhibited in the presence of 0.025% SDS (25). Taken together, these results suggest that the covalent attachment of O-glycans to secreted or cellular proteins in C. neoformans is critical for maintaining cell wall strength and integrity.
Numerous cell wall and cell membrane proteins are O mannosylated in other fungi, thereby contributing to cell surface integrity. Mannosyltransferase function may therefore have a widespread effect on protein targets. For example, in C. albicans, the Kre9 and Pir2 proteins are targets of Pmt1 activity and the Axl2 protein is a target of Pmt4 activity (32). Furthermore, C. albicans, pmt1 and pmt4 homozygous mutants underglycosylate the Sec20 protein, a crucial component of the secretory machinery, and therefore exhibit a significant decrease in cell wall mannoprotein content relative to wild-type cells (32).
The Wsc proteins and Mid2 protein are plasma membrane sensors upstream of the protein kinase C-mitogen-activated protein kinase pathway involved in the maintenance of cell wall integrity in S. cerevisiae (11, 42). Lommel et al. reported that WSC protein family members and Mid2 are abnormally cleaved in S. cerevisiae pmt mutants and that Pmt2- and Pmt4-mediated O mannosylation stabilizes and promotes the correct processing of Wsc1, Wsc2, and Mid2 (22) Furthermore, S. cerevisiae strains demonstrated increased osmotic sensitivity when multiple PMT genes were mutated (6). Disruption of the PMTA gene in A. nidulans indicated that Pmt activity is important for cell wall formation, as the pmtA mutant exhibited a decrease in cell wall rigidity and an abnormal morphology (27).
In light of these observations, it is conceivable that loss of Pmt4 also significantly impacts protein function in C. neoformans. Indeed, proteomic analysis of cell surface-associated proteins from the C. neoformans pmt4 strain revealed dramatic differences in global protein glycosylation and proteome distribution compared to the reconstituted strain. Several of the proteins present in the horizontal spot patterns resemble multiple glycoisoforms, which can be indicative of defective glycosylation (45, 47). These glycoisoforms observed in the pmt4 strain may represent Pmt4 targets. Ongoing studies will lead to the identification of such potential Pmt4 targets as well as the corresponding glycosylation modifications.
It is possible that, in the absence of Pmt4-initiated O-glycan biosynthesis, compensatory mechanisms may enable limited protein glycosylation to sustain viability. For example, the proteome pattern resembling multiple glycoforms suggests that Pmt1 and Pmt2 may attempt to compensate for Pmt4 loss, thus generating multiple glycosylation states of certain proteins. The qualitative decrease in the number of visible protein spots in the pmt4 2-D gel could be due to defective protein secretion, since O-glycans can act as a sorting signal for cell surface delivery of proteins (33). Also, certain protein motifs without Pmt4-mediated glycosylation may be improperly processed and more susceptible to proteases (35). The results of proteomic analysis, taken together with observations in other fungi, suggest a compromise of protein secretion and function in the C. neoformans pmt4 strain to which cell wall and cell membrane defects may be attributed.
In the pathogenic fungus C. albicans, Pmt4 is required for full virulence. pmt4/pmt4 homozygous mutants are significantly attenuated in mouse models of hematogenously disseminated candidiasis (34). In our studies, we used two murine models of cryptococcal disease, intravenous and inhalation, to examine the role of Pmt4 in C. neoformans pathogenesis. Disruption of the PMT4 gene in C. neoformans resulted in attenuation of virulence in both models of cryptococcal disease, suggesting an important role for O mannosylation in C. neoformans pathogenesis. Furthermore, reintroduction of the wild-type PMT4 fully restored virulence to that of the wild-type strain. It is likely that the attenuation in the pmt4 mutant is attributable at least in part to basic cellular events such as the aberrant budding pattern, defective cell separation, and altered cell integrity that result from a loss of Pmt4-mediated protein O mannosylation within the cell. It is conceivable that the cell separation defect of the pmt4 mutant affected dissemination or physiological clearance mechanisms within the host. Li et al. recently described a "sugar-induced," protein-mediated cell flocculation phenotype in a C. neoformans serotype D strain in which "clump+" cells more readily adhered to macrophage-like J774 cells and were more efficiently taken up by complement-mediated phagocytosis (20). Survival of mice infected with "clump+" cells was significantly increased relative to those infected with "clump" cells (20). In addition, decreased O mannosylation of secreted proteins may also influence the immunological aspect of pathogenesis, such as the induction of T-cell responses (23, 24, 26, 29).
Intriguingly, the morphological phenotype of the pmt4 mutant in the spleen was different from that observed in the brain and lungs, where the pmt4 mutant cells were indistinguishable from wild-type cells (Fig. 9B). These differences observed in the morphology of the pmt4 strain in the lungs and brain compared to the spleen are possibly attributable to differences in growth, since the mutant cells eventually separate as the population of cells age and approach stationary phase in liquid culture. We hypothesize that growth conditions present in the lung and brain tissues are more favorable for C. neoformans growth than in the spleen, which is a lymphatic tissue normally abundant in lymphocytes and macrophages. It is also possible that host-specific factors in the brain and lung tissues compensate for the delayed cell separation and reduced cell wall integrity of the pmt4 strain.
The results described herein suggest that Pmt4 activity, or loss thereof, affects several protein targets. While a basal level of glycosylation is likely required for cell viability, identification of specific protein targets that are O mannosylated by Pmt4 is important for defining the mechanisms by which protein O mannosylation contributes to cellular events central to C. neoformans growth and pathogenesis. These results collectively indicate a multifaceted role for Pmt4-mediated protein O mannosylation in the cell budding morphology, cell separation, cell surface integrity and pathogenesis of C. neoformans.
This work was supported in part by an ASM Katrina Grant-in-Aid Award (G.M.O.), a Burroughs Wellcome Fund New Investigator Award in Molecular Pathogenic Mycology (K.L.B. and J.A.A.), a grant from the Board of Regents of the State of Louisiana (K.L.B.), and a grant from the W.M. Keck Foundation of Los Angeles. This work was also supported by NIH grants AI050128 (J.A.A.), AI055302 (D.S.F.), and AI054958 (P.W.).
Published ahead of print on 1 December 2006. ![]()
Present address: Department of Biology, Oklahoma City University, 2501 N. Blackwelder, Oklahoma City, OK 73106. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»